Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 2—February 2008

Methicillin-Resistant Staphylococcus aureus, Geneva, Switzerland, 1993–2005

Patrice Francois*1Comments to Author , Stephan Harbarth*1, Antoine Huyghe*, Gesuele Renzi*, Manuela Bento*, Alain Gervaix*, Didier Pittet*, and Jacques Schrenzel*
Author affiliations: *University of Geneva Hospitals, Geneva, Switzerland;

Main Article

Table 1

Demographic characteristics, types of infection, and epidemiologic profiles of 
61 patients with CA-MRSA colonization or infection, Geneva University Hospitals, 2002–2005*

Characteristic Value
Demographic data
Mean ± SD age, y 33 ± 21
Male 35 (57)
Immigrant, foreign origin or residency 
outside Switzerland 25 (41)
Recent history of travel before CA-MRSA 
isolation 29 (48)
Institutionalized (prison, nursing home, 
asylum-seeker camp) 11 (18)
Healthcare worker
4 (7)
Type of infection/colonization
Primary cutaneous abscess or pyoderma 27 (44)
Wound infection 4 (7)
Impetigo 3 (5)
Other 1 (2)
26 (43)
Site of skin infection (n = 27)
Head and face 6
Upper extremity 6
Trunk and buttock 7
Lower extremity
Other clinical features
Presence of >1 other medical condition 16 (26)
Previous exposure (<6 mo) to antimicrobial 
drug 16 (26)
Case-fatality mortality rate 0

*Values are no. (%) of patients unless otherwise indicated. For 2 patients, no microbiologic specimen was available for molecular characterization. See also supplementary material (available from CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus.

Main Article

1These authors contributed equally to this article.

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.